Tipranavir will increase the degree or outcome of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Check Carefully (one)belzutifan will lessen the extent or outcome of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. omaveloxolone will minimize the extent or result of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 meta... https://billx059kxg7.bcbloggers.com/profile